pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,333 catalysts · 3,126 8k filing · 576 earnings · 203 grant · 172 phase 2 completion · 163 approval · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-06×clear all
type
  • 8k filing3,126
  • earnings576
  • grant203
  • phase 2 completion172
  • approval163
  • drug shortage133
device 510k
81
  • phase 1 completion73
  • phase 2 initiation62
  • recall52
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 6, 2026

    50
    ›Apr 6, 2026grant128d agoUNIV OF NORTH CAROLINA CHAPEL HILL — A Trial of Upadacitinib for Non-responsive Eosinophilic esophagitis (ATUNE)AbbVie Inc.

    DK grant. $781,365. PI: Seema S Aceves

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF MARYLAND BALTIMORE — Modeling the Vaginal Microbiome: Predicting BV Recurrence and Identifying Pre...

    AI grant. $427,625. PI: Johanna B. Holm

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Investigating the role of A-to-I RNA editing by ADARs in corticogenesis using...University of California San Diego

    MH grant. $43,784. PI: Summer Rose Fair

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoYALE UNIVERSITY — Novel Gene Variants of ZFYVE21 and Dysregulated Innate Immunity

    AI grant. $778,828. PI: CLARA ABRAHAM

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoEMORY UNIVERSITY — Targeting androgen-driven resistance to immune checkpoint inhibitors in pancr...Emory University

    CA grant. $402,401. PI: Kiranj Chaudagar

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Interplay of heterosexual male-female partner microbiomes, Chlamydia trachoma...University of California San Francisco

    AI grant. $816,421. PI: DEBORAH Anne DEAN

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Elucidating The Immunoregulatory Role of Dendritic Cell Subsets in Periodonta...

    DE grant. $320,660. PI: Araceli Maria Valverde

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Genetic and Gut Microbial Regulation of Indole-3 Propionate in Metabolic DiseaseUniversity of California Los Angeles

    DK grant. $778,662. PI: Hooman Allayee

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF NEBRASKA MEDICAL CENTER — Reassessing West Nile virus action thresholds for improved disease control

    AI grant. $436,157. PI: BRIAN David FOY

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF TEXAS AT AUSTIN — Mechanisms of the interplay between metabolism, chromatin regulation, and tra...

    GM grant. $429,650. PI: Hong Qiao

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF MONTANA — Inter-strain recombinants of human cytomegalovirus as an in vitro model of in...

    AI grant. $147,000. PI: BRENT J. RYCKMAN

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoLSU HEALTH SCIENCES CENTER — Screening and validation of miRNA targets for neurogenic hypertension.

    HL grant. $1,008,719. PI: Eric D Lazartigues

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF PENNSYLVANIA — Elucidating the Mechanisms and Roles of RNA Editing and SensingUniversity of Pennsylvania

    GM grant. $446,875. PI: Qin Li

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoBRIGHAM AND WOMEN'S HOSPITAL — Immune regulatory role of reactive oxygen species (ROS) in sepsisBrigham and Women's Hospital

    AI grant. $760,700. PI: Hongbo R Luo

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoUNIVERSITY OF WISCONSIN-MADISON — Protective mRNA Vaccines Against Tuberculosis

    AI grant. $717,003. PI: ADEL M TALAAT

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — A Cluster Randomized Stepped-Wedge Effectiveness-Implementation Trial of a Pa...

    AI grant. $872,037. PI: Lauren Stephanie Chernick

    full page →nih reporter ↗
    ›Apr 6, 2026grant128d agoAPPLIED BIOMEDICAL SCIENCE INSTITUTE — Unique Antibody Structural Variegation Mechanisms

    AI grant. $976,318. PI: Vaughn Vasil Smider

    full page →nih reporter ↗
    ›04/07/2026recall127d agoDTF Sexual Chocolate recall: Food & Beverages

    Chocolate

    full page →fda recalls ↗
    ›Apr 7, 2026approval127d agoNITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN) — FDA approvalCreekwood Pharmaceutical Inc

    Sponsor: CREEKWOOD PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 7, 2026approval127d agoBEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalnirsevimab

    Sponsor: ASTRAZENECA AB. Form: INJECTABLE. Route: INJECTION

    full page →nirsevimab →fda approvals ↗
    ›Apr 7, 2026approval127d agoPLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvallutetium Lu 177 vipivotide tetraxetan

    Sponsor: NOVARTIS. Form: SOLUTION. Route: INTRAVENOUS

    full page →lutetium Lu 177 vipivotide tetraxetan →fda approvals ↗
    ›Apr 7, 2026approval127d agoIVERMECTIN — FDA approvalIVERMECTIN

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →IVERMECTIN →fda approvals ↗
    ›Apr 7, 2026approval127d agoSKYCLARYS (OMAVELOXOLONE) — FDA approvalReata Pharmaceuticals Inc

    Sponsor: BIOGEN US. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 7, 2026approval127d agoCEFEPIME AND DEXTROSE IN DUPLEX CONTAINER (CEFEPIME HYDROCHLORIDE) — FDA approvalSamson Medical Technologies LLC

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 7, 2026approval127d agoEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE) — FDA approvalemtricitabine

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →emtricitabine →fda approvals ↗
    ›Apr 7, 2026device 510k127d agoHangzhou Tappa Medical Technology Co., Ltd. — Warming System (510k cleared)Guangzhou Dazhou Biomedical Technology Co Ltd

    Product code: DWJ. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoZhejiang shuyou Surgical Instrument Co., Ltd. — Multifunctional Operational Dissectors (Electrosurgical Pencils);Multifunctional Operational Dissectors (Disposable Electrode) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoRoche Diagnostics — Elecsys Anti-HAV IgM (510k cleared)

    Product code: LOL. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoBelkin Vision, Ltd. — Voyager DSLT (430840610) (510k cleared)

    Product code: HQF. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoRoche Diagnostics — Elecsys Anti-HBc II (510k cleared)

    Product code: SEI. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoRoche Diagnostics — Elecsys Anti-HBc IgM (510k cleared)

    Product code: SEI. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoInnovaCorium, Inc. — IWD-Gel™ (510k cleared)

    Product code: FRO. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoBasic Medical Technology, Inc. — Powder Free Synthetic Vinyl Exam Gloves (Blue, Black) (510k cleared)Medical Care Technologies Inc.

    Product code: LYZ. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoShenzhen Root Innovation Technology Co., Ltd. — Momcozy Wearable Breast Pump (S9 Pro, S9 Pro-A, S9 Pro-B, S9 Pro-C, S9 Pro-D, S9 ProY-A, S9 ProY-B, S9 ProY-C, S12 Pro, S12 Pro-A, S12 Pro-B, S12 Pro-C, S12 Pro-D, S12 ProY-A, S12 ProY-B, S12 ProY-C) (510k cleared)Hang Feng Technology Innovation Co., Ltd.

    Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoBeijing OrionStar Technology Co., Ltd. — Power Wheelchair (OS-R-M01S) (510k cleared)

    Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoShanghai MicroPort Medical (Group) Co., Ltd. — Firefighter™ Pro PTCA Balloon Catheter (510k cleared)

    Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoAnumana, Inc. — ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040) (510k cleared)

    Product code: SHP. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoCenterPoint Systems, LLC — AuST Steerable Sheath (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Apr 7, 2026device 510k127d agoCogentix Medical, Inc. — PrimeSight UltraView System (510k cleared)

    Product code: FAJ. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 7, 2026device pma127d agoW. L. Gore & Associates, Inc. — GORE® VIABAHN® FORTEGRA Venous Stent (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: QTL. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoMedtronic — HeartWare HVAD System (PMA supplement)Medtronic plc

    Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoCerapedics, LLC — i-FACTOR® Peptide Enhanced Graft Substitute (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NOX. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoCerapedics, Inc. — PearlMatrix™ Peptide Enhanced Bone Graft (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NOX. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoAbiomed, Inc. — Impella 5.5 with Smart Assist (PMA supplement)Abion Inc

    Supplement type: 30-Day Notice. Product code: OZD. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoBoston Scientific Corporation — Axonics Sacral Neuromodulation System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Apr 7, 2026device pma127d agoTeoxane S.A. — RHA 2, RHA 3, RHA 4 (PMA supplement)

    Supplement type: Real-Time Process. Product code: LMH. Advisory committee: SU. Decision: APPR

    full page →fda device pma ↗
    ›Apr 7, 2026grant127d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Durability of memory T cell responses in melanoma

    CA grant. $660,808. PI: Christina Vadala Angeles

    full page →nih reporter ↗
    ›Apr 7, 2026grant127d agoCORNELL UNIVERSITY — Understanding the mechanisms of maternal antibody interference with oral vacc...

    AI grant. $653,742. PI: Sarah Caddy

    full page →nih reporter ↗
    ›Apr 7, 2026grant127d agoYALE UNIVERSITY — Investigating mechanisms of CD8 T cell differentiation in the tumor-draining ...

    CA grant. $696,189. PI: Nikhil Joshi

    full page →nih reporter ↗
    ← prev
    page 2 of 87
    next →
    $ABBV249.50+0.61%
    $MDT90.68+1.42%
    $NVS155.21-1.01%
    $MDCE0.00020.00%
    $BSX51.32+1.70%
    $FOFO3.0000+2.39%
    $BSX51.32+1.70%
    $AZN158.75-1.95%